- Home
- TVTX vs DOLE Comparison
TVTX vs DOLE Comparison
Compare TVTX & DOLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- DOLE
- Stock Information
- Founded
- TVTX 2008
- DOLE 1851
- Country
- TVTX United States
- DOLE Ireland
- Employees
- TVTX N/A
- DOLE N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- DOLE Farming/Seeds/Milling
- Sector
- TVTX Health Care
- DOLE Consumer Staples
- Exchange
- TVTX Nasdaq
- DOLE Nasdaq
- Market Cap
- TVTX 1.3B
- DOLE 1.3B
- IPO Year
- TVTX N/A
- DOLE 2021
- Fundamental
- Price
- TVTX $14.92
- DOLE $13.94
- Analyst Decision
- TVTX Strong Buy
- DOLE Buy
- Analyst Count
- TVTX 13
- DOLE 3
- Target Price
- TVTX $33.75
- DOLE $16.67
- AVG Volume (30 Days)
- TVTX 2.0M
- DOLE 605.7K
- Earning Date
- TVTX 05-05-2025
- DOLE 05-14-2025
- Dividend Yield
- TVTX N/A
- DOLE 2.31%
- EPS Growth
- TVTX N/A
- DOLE 1.30
- EPS
- TVTX N/A
- DOLE 1.32
- Revenue
- TVTX $233,175,000.00
- DOLE $8,475,343,000.00
- Revenue This Year
- TVTX $68.31
- DOLE $2.38
- Revenue Next Year
- TVTX $55.65
- DOLE $1.95
- P/E Ratio
- TVTX N/A
- DOLE $8.60
- Revenue Growth
- TVTX 60.55
- DOLE 2.79
- 52 Week Low
- TVTX $5.12
- DOLE $11.53
- 52 Week High
- TVTX $25.29
- DOLE $17.12
- Technical
- Relative Strength Index (RSI)
- TVTX 37.07
- DOLE 49.17
- Support Level
- TVTX $14.13
- DOLE $13.67
- Resistance Level
- TVTX $15.23
- DOLE $13.96
- Average True Range (ATR)
- TVTX 1.31
- DOLE 0.47
- MACD
- TVTX -0.10
- DOLE -0.02
- Stochastic Oscillator
- TVTX 31.70
- DOLE 50.29
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About DOLE Dole plc
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW and Fresh Vegetables. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.